Lumiliximab (Anti-FceR2 / CD23)

製品コード：A2501        

印刷

Lumiliximab (Anti-FceR2 / CD23) is a monoclonal antibody targeting CD23, that inhibits allergen-induced responses. MW: 145.5 KD.

製品説明

CAS No. 357613-86-6
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Isotype Human IgG1
Source CHO
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Shipping Shipped under low temperature conditions

人間や獣医の診断であるか治療的な使用のためにでない。